While precision medicine has started to inch its way to becoming a norm in healthcare, there are still barriers holding back widespread implementation amomg providers and organizations.
While precision medicine has started to inch its way to becoming a norm in healthcare, there are still barriers holding back widespread implementation amomg providers and organizations. From reimbursement challenges to primary use in oncology to proving the return on investment of implementing a precision medicine program, addressing these barriers could open the door to more providers and oragnizations embracing precision medicine in their practice.
To discuss these challenges and ways to mitigate them, we sat down with Joel Diamond, MD, a practicing physician, adjunct associate professor of Biomedical Informatics at the University of Pittsburgh, and cofounder and chief medical officer of 2bPrecise.
Listen above or through one of these podcast services:
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen